CUSIP 28658R106 · who reports it, how much, and how much it matters to them
18 of the 720 hedge fund managers we track reported shares of Climb Bio, Inc. (Nasdaq: CLYM) on Form 13F for 30 June 2026. Between them they reported USD 328m. The largest position belongs to Ra Capital Management, at USD 147m. The manager with the most riding on it is Superstring Capital Management, where it is 4.3% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 147m | 1.3% |
| 2 | Braidwell12 funds on PPLI.com | USD 36m | 1.3% |
| 3 | Adage Capital Management1 fund on PPLI.com | USD 33m | 0.0% |
| 4 | Cormorant Asset Management1 fund on PPLI.com | USD 27m | 1.4% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 17m | 0.0% |
| 6 | Redmile Group10 funds on PPLI.com | USD 16m | 1.1% |
| 7 | Great Point Partners2 funds on PPLI.com | USD 13m | 2.5% |
| 8 | Millennium Management6 funds on PPLI.com | USD 12m | 0.0% |
| 9 | Superstring Capital Management1 fund on PPLI.com | USD 6.8m | 4.3% |
| 10 | Sphera Funds Management1 fund on PPLI.com | USD 6.3m | 0.8% |
| 11 | Ally Bridge Group (Ny)3 funds on PPLI.com | USD 3.2m | 2.9% |
| 12 | Renaissance Technologies13 funds on PPLI.com | USD 2.5m | 0.0% |
| 13 | Boothbay Fund Management2 funds on PPLI.com | USD 2.4m | 0.0% |
| 14 | Two Sigma Investments35 funds on PPLI.com | USD 1.9m | 0.0% |
| 15 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.6m | 0.0% |
| 16 | Verdad Advisers6 funds on PPLI.com | USD 601,000 | 0.6% |
| 17 | D. E. Shaw & Co.15 funds on PPLI.com | USD 376,000 | 0.0% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 338,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Superstring Capital Management | USD 6.8m | 4.3% |
| 2 | Ally Bridge Group (Ny) | USD 3.2m | 2.9% |
| 3 | Great Point Partners | USD 13m | 2.5% |
| 4 | Cormorant Asset Management | USD 27m | 1.4% |
| 5 | Braidwell | USD 36m | 1.3% |
| 6 | Ra Capital Management | USD 147m | 1.3% |
| 7 | Redmile Group | USD 16m | 1.1% |
| 8 | Sphera Funds Management | USD 6.3m | 0.8% |
| 9 | Verdad Advisers | USD 601,000 | 0.6% |
| 10 | Adage Capital Management | USD 33m | 0.0% |
Climb Bio, Inc. trades under the symbol CLYM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 28658R106.
18 of the 720 hedge fund managers PPLI.com tracks reported Climb Bio, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 147m), Braidwell (USD 36m), Adage Capital Management (USD 33m), Cormorant Asset Management (USD 27m) and Citadel Advisors (USD 17m).
18 managers in our coverage reported it, and between them they run 178 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Superstring Capital Management, where the position was 4.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Climb Bio, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.